The helix was packed diagonally across one side of the five-stranded sheet (Fig. total growth inhibition, implying an essential requirement for this domain Compound 401 name. A high resolution structure of the NTD of TbBILBO1 showed that it forms a ubiquitin-like fold with a conserved surface patch. Mutagenesis of this patch recapitulated the phenotypic effects of deleting the entire domain name and was found to cause cell death. The surface patch around the NTD of TbBILBO1 is usually therefore a potential drug target. == Introduction == Trypanosomes are protists belonging to Compound 401 the class Kinetoplastida, one of the early branching lineages around the eukaryotic tree (1). Trypanosomes follow an exclusively parasitic way of life and are significant pathogens of both humans and livestock worldwide. In humans,Trypanosoma bruceicauses sleeping sickness in Africa, Trypanosoma cruzicauses Chagas disease in the tropical areas in Central and South America, andLeishmaniaspecies are responsible for leishmaniasis in Africa and South Asia (24). Currently, there is no vaccine and few available drugs. Many of the drugs that are currently in use are inadequate due to high incidences of (sometimes lethal) side effects (5,6). Therefore, there are persuasive reasons to identify and characterize novel drug targets. Trypanosome cells are enclosed in a corset of microtubules that run beneath the plasma membrane, giving them their characteristic serpentine shape (7). A single flagellum runs Compound 401 from your posterior to the anterior end of the cell and imparts motility (27). The root of the flagellum is within an invagination of the plasma membrane called the flagellar pocket (FP),4which is usually abutted by the basal body nucleating the flagellum (8). Even though it constitutes only 5% of the total plasma membrane, the FP is the single site for all those endo- and exocytic activities (911). At the neck of the FP is an electron-dense structure termed the flagellar pocket collar (FPC). The protein TbBILBO1 is the only known FPC component (12). It was shown previously that depletion of TbBILBO1 by RNAi prevents FP and FPC biogenesis and prospects to cell death (12). Orthologs of TbBILBO1 are found in all trypanosomatids, but no homologous protein is present in humans. As such, TbBILBO1 represents a plausible candidate for rational drug design. TbBILBO1 is usually a modular protein with a distinct N-terminal domain name (NTD). The results described here provide a high resolution structure for this domain name and a demonstration of its essential requirementin vivo. In particular, a conserved surface patch was implicated as a potential site for pharmacological blockade. == EXPERIMENTAL PROCEDURES == == == == == == Antibodies and Reagents == The rabbit anti-LdCentrin4 polyclonal antibody and mouse monoclonal anti-Ty1 (BB2) antibody were gifts kindly received from Hira Nakhasi (FDA) and Cynthia He (National University or college of Singapore). The following antibodies were obtained from commercial sources: HRP-conjugated anti-mouse (Pierce), HRP-conjugated anti-rabbit (Dianova) mouse anti–tubulin (Roche Applied Science), anti-GFP (Roche Applied Science), Alexa Fluor 488 goat anti-mouse (Invitrogen), and Alexa Fluor 568 goat anti-rabbit (Invitrogen). An Annexin V-FITC apoptosis detection kit was purchased from eBioscience. Ammonium chloride (15N, 99%) andd-Glucose (13C, 99%) were purchased from Cambridge Isotope Laboratories, Inc. and Euriso-top, respectively. == Cloning and Site-directed Mutagenesis == The full-length TbBILBO1 (TbBILBO1-FL) open reading frame was amplified by PCR from genomic DNA and ligated into the custom vector HM15b. The vector provides an N-terminal His6tag (cleavable by thrombin) and an N-terminal maltose-binding protein tag. All TbBILBO1 constructs were subcloned from TbBILBO1-FL. TbBILBO1 localization constructs were generated by amplification of the relevant portions of the TbBILBO1 open reading frame by PCR, with addition of a BamHI restriction enzyme site and a 5-end Ty1 epitope tag. The PCR products were ligated into the pXS2 expression vector using the BamHI site to generate the pXS2-TbBILBO1 plasmids (14). The TbBILBO1-NTD (encoding residues 1110) for NMR structure determination was cloned into pET15b (Novagen). For the generation of stable cell lines, the TbBILBO1-FL and TbBILBO1-NTD (encoding residues 111587) open reading frames were amplified from your HM15b-TbBILBO1-FL shuttle vector by PCR with the addition of HindIII and BamHI restriction enzyme sites and a 5-end sequence encoding a Ty1 epitope tag. They were ligated into the pLEW100 expression vector INSR using HindIII and BamHI sites to generate the pLEW100-TbBILBO1 plasmids. Mutations in the NTD of TbBILBO1 were generated by site-directed mutagenesis around the pLEW100-TbBILBO1-FL plasmid using a QuikChange kit (Stratagene) according to the.